Some previous studies reported that interferon and direct acting antivirals (DAAs) helped in recovery from the imbalance between ADAMTS13 enzyme and VWF substrate and high Et levels in patients with LC and hepatitis C [8,49,50]. The gene discussed is VWF; the disease is laryngotracheoesophageal cleft.